Browse Pet Safety Reports
18,045 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,045 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,045 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Feb 26, 2024 | Horse | Quarter Horse | Omeprazole | INEFFECTIVE, GASTRIC ULCER(S); Partial lack of efficacy | Ongoing |
| Feb 24, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Feb 23, 2024 | Horse | Unknown | Gentamicin Sulfate | Death | Died |
| Feb 23, 2024 | Horse | Arab, Horse (unknown) | Ivermectin; Praziquantel | Tarry or black stool (see also haemorrhagic diarrhoea); Anorexia; Application... | Outcome Unknown |
| Feb 22, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Feb 22, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Feb 21, 2024 | Horse | Warmblood - Dutch | Flunixin Meglumine Oral Paste | Lack of efficacy - NOS | Ongoing |
| Feb 20, 2024 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Ataxia | Ongoing |
| Feb 20, 2024 | Horse | Paint | Butorphanol Tartrate | Head bobbing; Underdose | Recovered/Normal |
| Feb 20, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Feb 20, 2024 | Horse | Paint | Xylazine | Head bobbing | Recovered/Normal |
| Feb 20, 2024 | Horse | Quarter Horse | Equine Leucoreduced Allogeneic Pooled... | Hepatitis | Ongoing |
| Feb 18, 2024 | Horse | Horse (other) | Polysulfated Glycosaminoglycan | Hair coat discolouration; Injection site hair change | Outcome Unknown |
| Feb 18, 2024 | Horse | Connemara Pony | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Feb 18, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Rubbing; Hyperactivity; Hives (see also Skin); Hypersensitivity reaction | Recovered/Normal |
| Feb 17, 2024 | Horse | Quarter Horse | Pergolide Mesylate | Agitation; Muscle spasm NOS | Recovered/Normal |
| Feb 16, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Feb 15, 2024 | Horse | Quarter Horse | Clodronate Disodium | Epistaxis (unilateral) | Outcome Unknown |
| Feb 15, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site swelling | Recovered/Normal |
| Feb 14, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Feb 13, 2024 | Horse | Thoroughbred | Detomidine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Feb 13, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Lethargy (see also Central nervous system depression in Neurological); Not ea... | Outcome Unknown |
| Feb 13, 2024 | Horse | Thoroughbred | Detomidine Hydrochloride | INEFFECTIVE, SEDATION | Recovered/Normal |
| Feb 13, 2024 | Horse | Warmblood (unspecified) | Detomidine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Feb 13, 2024 | Horse | Warmblood (unspecified) | Detomidine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Feb 12, 2024 | Horse | Welsh Cob | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Feb 12, 2024 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Injection site inflammation | Ongoing |
| Feb 12, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site swelling; Injection site tenderness; Muscle tremor; Stiffness NOS | Outcome Unknown |
| Feb 12, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site alopecia | Outcome Unknown |
| Feb 12, 2024 | Horse | Arab | Pergolide Mesylate | Anorexia | Outcome Unknown |
| Feb 11, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site pain; Decreased appetite; Elevated temperature; Lethargy (see ... | Outcome Unknown |
| Feb 9, 2024 | Horse | Irish Cob (Tinker) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Feb 9, 2024 | Horse | Horse (unknown) | Hyaluronate Sodium | Elevated liver enzymes NOS | Outcome Unknown |
| Feb 9, 2024 | Horse | Warmblood - Dutch | Pentosan Polysulfate Sodium | Polyuria; Decreased appetite; Dullness; Lethargy (see also Central nervous sy... | Outcome Unknown |
| Feb 9, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site swelling; Injection site pain; Reluctant to move | Outcome Unknown |
| Feb 8, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Feb 8, 2024 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Hyperexcitation; Death | Died |
| Feb 7, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Feb 6, 2024 | Horse | Thoroughbred | Pentosan Polysulfate Sodium | Injection site swelling; Injection site stiffness; Injection site warmth; Inj... | Outcome Unknown |
| Feb 6, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Feb 6, 2024 | Horse | Quarter Horse | Detomidine Hydrochloride | Sedation prolonged; Balance impaired; Incorrect storage of drug | Recovered/Normal |
| Feb 6, 2024 | Horse | Quarter Horse | Omeprazole | INEFFECTIVE, GASTRIC ULCER(S); Overdose | Ongoing |
| Feb 5, 2024 | Horse | Horse (other) | Ponazuril | Local swelling (not application site); Other abnormal test result NOS; Abdomi... | Ongoing |
| Feb 5, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site swelling; Injection site pain | Recovered/Normal |
| Feb 5, 2024 | Horse | Crossbred Equine/horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Feb 3, 2024 | Horse | Arab | Ceftiofur Crystalline Free Acid | Injection site swelling | Recovered/Normal |
| Feb 2, 2024 | Horse | Arab | Omeprazole | Inappropriate schedule of drug administration; INEFFECTIVE, GASTRIC ULCER(S) | Recovered/Normal |
| Feb 2, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Feb 1, 2024 | Horse | Pony (unspecified) | Pergolide Mesylate | Lack of efficacy - NOS | Ongoing |
| Feb 1, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.